Cope

Quick links to important sections

Cope

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cope

Quick Facts

Property Description
Active Ingredients Acetylsalicylic Acid (ASA), Caffeine
Form Oral Tablet, Oral Capsule
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID) and Central Nervous System (CNS) Stimulant Combination
Common Use Mild to moderate pain relief, Fever reduction
Origin Synthetic

What Type of Medicine is Cope and What is its Composition?

Cope is an established Over-the-counter (OTC) combination analgesic, which is a multi-ingredient formulation blending an NSAID and a CNS Stimulant. It is supplied in a synthetic form designed for the oral route of administration as a tablet or capsule. This specific dual composition, featuring Acetylsalicylic Acid (ASA) and Caffeine, differentiates it from single-agent pain relievers. The Acetylsalicylic Acid component places the drug within the Salicylate class, possessing established antipyretic properties and acting to inhibit the synthesis of pain-promoting substances. Caffeine is included specifically for its clinically recognized adjuvant effect, which confirms its role in boosting the overall therapeutic result of the primary analgesic.

What is the General Purpose of the Acetylsalicylic Acid and Caffeine Combination?

The general therapeutic purpose of the Cope combination is to provide effective, simultaneous relief from the symptoms of mild to moderate pain, notably headache, and elevated body temperature. The formulation capitalizes on the complementary actions of its two components to achieve an enhanced benefit. The inclusion of the Caffeine component provides a recognized adjuvant effect that increases the speed and magnitude of the analgesic action. This synergy results in effectiveness for acute tension-type headache compared to placebo and single-drug entities. This positions the preparation as a broadly utilized non-opioid choice for acute discomforts experienced by adults, focusing on the rapid management of pain and fever.

Regulatory References

  1. Aspirin: MedlinePlus Drug Information

What side effects are possible with Cope?

Possible Side Effects and Safety Information

The safety profile of Cope, which contains nonsteroidal anti-inflammatory (NSAID) and stimulant ingredients, is officially documented by regulatory agencies to help users understand associated risks. Adverse reactions are classified by system-organ class and frequency.

Serious and Clinically Significant Adverse Reactions

The most serious safety risks, as highlighted in official labeling, include Gastrointestinal Bleeding and Ulceration, which can be fatal, and Severe Allergic Reactions (hypersensitivity and anaphylaxis) that require immediate medical attention.

Another critical risk is Reye’s Syndrome, a rare but severe and potentially fatal condition primarily affecting children and teenagers who take the product while recovering from flu symptoms or chickenpox. Due to this risk, the product is contraindicated for use in this population when those symptoms are present.

Adverse Reaction Summary (Commonly Reported)

Adverse reactions that are frequently reported, typically categorized as Common or Very Common, often involve the gastrointestinal and nervous systems. These include nausea, vomiting, stomach pain, nervousness, irritability, and sleep disturbances (insomnia).

System-Organ Class Common Adverse Reactions
Gastrointestinal Disorders Nausea, Vomiting, Stomach Pain
Nervous System Disorders Nervousness, Insomnia, Dizziness

Safety Restrictions and Monitoring

Contraindications include a documented allergy to the product or any NSAIDs. The product should be used with caution in geriatric patients, those with a history of stomach ulcers, bleeding problems, heart conditions, or kidney and liver disease. Consistent with official label warnings, use in the last trimester of pregnancy is not recommended due to risk of harm to the fetus. Monitoring for signs of gastrointestinal bleeding or severe hypersensitivity is necessary.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents define the overdose profile for this Acetylsalicylic Acid and Caffeine combination based on documented systemic toxicity.

Manifestations and Severe Outcomes

An overdose may initially present with symptoms such as tinnitus, nausea, vomiting, hyperventilation, and confusion. Manifestations of CNS overstimulation, including tremor and tachycardia, are also officially documented. Severe systemic outcomes include progression to metabolic acidosis, hyperthermia, and significant CNS depression, which can lead to seizures or coma. Non-cardiogenic pulmonary edema and cardiac arrhythmias are also listed as life-threatening complications.

Emergency Actions Required

Regulatory labeling mandates that individuals seek immediate medical attention for any suspected overdose, even if the symptoms appear mild. Individuals must contact emergency services immediately upon the occurrence of severe, documented manifestations such as severe lethargy, seizures, or profound hyperthermia. Official procedures describe that management focuses on symptomatic and supportive treatment, including the consideration of gastric decontamination and methods for enhanced drug elimination, such as urine alkalinization or hemodialysis for severe cases. No specific antidote is known for this combination product.

Population Considerations

Toxicity is officially noted to be potentially more severe and rapid in young children and carries an increased risk of serious outcomes in patients with pre-existing renal or hepatic impairment.

Therapeutic Uses of Cope

Quick Facts: Cope's Main Uses

  • Addresses symptoms associated with: Headaches
  • Provides relief for: Minor body aches and discomfort
  • Helps manage: Fever and pain related to conditions like minor arthritis
  • Includes management for: Menstrual cramps

What Cope Treats: Main Uses and Benefits

Cope is intended to provide temporary relief for various forms of discomfort. The formulation may assist in the alleviation of symptoms associated with common conditions, including headaches, general body aches, and minor muscle discomfort. This compound is also employed in the management of fever and minor pain linked to certain conditions, such as mild arthritis.

Furthermore, the medication is indicated for the relief of pain associated with menstrual cramps. It functions to address these mild to moderate symptoms, allowing the individual to continue with daily activities. As a combination product, it is intended for use by adults and children over the age of 12 for these specific indications.

Regulatory References

  1. NIH MedlinePlus guidance on pain relievers

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Cope (referencing the active ingredient Cetirizine hydrochloride) is defined by regulatory agencies as having specific eligibility rules for use.

Absolute Contraindications

The medicine must not be used if a patient has a documented hypersensitivity to cetirizine, its related compounds (like hydroxyzine or piperazine derivatives), or any excipients in the product. It is also contraindicated for patients with severe renal impairment or end-stage kidney disease (e.g., Creatinine Clearance typically below 15 mL/min).

Restricted and Conditional Use

Population Regulatory Status
Children Under 6 The tablet form is not recommended due to required dose adjustments.
Renal Impairment Requires dose reduction or adjusted dosing interval based on kidney function.
Pregnancy Use is permitted, but only with caution and if necessary.
Breastfeeding Not recommended as the drug passes into breast milk.
Specific Conditions Caution is advised for patients with epilepsy or a risk of urinary retention.

Eligibility is also generally established for adults, adolescents, and children over 6 years of age (with appropriate formulations).

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for the Acetylsalicylic Acid (ASA) and Caffeine combination, strictly based on regulatory labeling.


Interaction Scope

Category Official Regulatory Information for Cope (ASA/Caffeine)
Medicinal product categories with documented interactions Anticoagulants, Antiplatelet agents, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Selective Serotonin Re-uptake Inhibitors (SSRIs), Glucocorticoids, Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Uricosuric agents, Oral Contraceptives, Alcohol, Caffeine-containing products.
Specific interacting medicines (if explicitly listed) Methotrexate (ge 15 mg/week), Digoxin, Lithium, Cimetidine.
Mechanistic basis of interactions (only if stated in label) Altered renal clearance (of Methotrexate, Digoxin); Reduced uricosuric effect (renal tubular competition); Altered hepatic degradation of Caffeine (PK); Additive bleeding risk (Pharmacodynamic); Antagonism of antihypertensive/diuretic effect (Pharmacodynamic).

Interaction Classifications

Category Official Regulatory Classification/Context
Interaction severity classification Contraindicated (e.g., high-dose Methotrexate); Avoided/Not Recommended (e.g., other NSAIDs, Alcohol); Caution/Limit Use (e.g., Anticoagulants, Caffeine sources).
Population-specific interaction notes Use in children and teenagers with viral illnesses (flu, chickenpox) is prohibited due to the risk of Reye's syndrome; Elderly patients are at increased risk of gastrointestinal bleeding.

Official interaction statements:

Regulatory documentation establishes that co-administration with Methotrexate (ge 15 mg/week) is contraindicated due to documented decreased renal clearance, potentially increasing exposure. The combination with Anticoagulants, Antiplatelet agents, and SSRIs is associated with an increased risk of bleeding due to additive pharmacodynamic effects. Alcohol co-ingestion is formally restricted due to the documented increased risk of stomach bleeding. Additionally, the label requires limiting the intake of caffeine-containing products to avoid excessive intake and its potential effects on the central nervous system. The interaction profile also notes that some drugs, such as Glucocorticoids and Cimetidine, may alter the body's clearance of the active components.

Mechanism of Action

Cope is a selective non-peptide agent that modulates the A1R receptor complex. Its mechanism involves non-competitive antagonism at the A1R binding site, specifically disrupting the conformational changes necessary for receptor activation. This binding leads to functional suppression of the downstream NF-kappa B pathway, effectively decreasing the internal signal transduction cascade. At the intracellular level, this NF-kappa B suppression alters gene transcription, resulting in reduced expression of key osteoclastogenesis-related factors, such as RANKL. Consequently, the drug modifies the biological processes that govern osteoclast differentiation and activity, shifting the physiological balance in favor of reduced bone resorption and maintenance of bone structural integrity at the tissue level.

Dosage and Administration Information

How to Use Cope

The administration of Cope (Acetylsalicylic Acid and Caffeine) follows a standardized set of instructions focusing on the method, dosage, and timing of the oral form. This medication is intended for temporary symptom management on an as-needed basis, strictly adhering to the established limits for this formulation.


Official Administration Guidelines

Instruction Category Official Guideline
Route of administration Oral administration only, supplied as a tablet or capsule.
Dosing schedule The standard dose for adults and children 12 years and over is two dosage units (totaling 1000 mg of ASA) per dose. The maximum daily intake of Acetylsalicylic Acid must not exceed 4000 mg in a 24-hour period.
Frequency and timing Doses should be taken every 6 hours as needed for symptoms. The medicine is not intended for continuous use; it should not be used for pain for more than 10 days or for fever for more than 3 days.

Procedural Structure and Conditions

The correct procedure for taking Cope mandates that the oral unit be swallowed with a full glass of water. This instruction is essential for proper administration. The label permits taking the dose alongside food or milk if stomach upset occurs. The medicine is approved for use in adults and children who are 12 years of age and over. Use in pediatric patients under 12 years is not authorized under the non-prescription label. The procedural structure is designed around on-demand use, establishing clear boundaries for the dose and the mandatory 6-hour minimum interval between doses.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Cope (ASA + Caffeine)

This overview summarizes the available research regarding the clinical evaluation of the active components of Cope (Acetylsalicylic Acid and Caffeine), focusing strictly on the structure of the evidence and what studies have examined. This information is purely descriptive and does not offer clinical recommendations or guidance.


Evidence for Use in Acute Headache (Tension-Type and Migraine)

The research relevant to this combination in headache has been studied primarily through numerous short-term Randomized Controlled Trials (RCTs) and consolidated by large-scale Systematic Reviews and Meta-analyses. These studies were used in research exploring how symptoms change over time and involved adults experiencing a single, acute episode of tension-type headache or migraine. Researchers monitored various outcomes, including how quickly individuals achieved the achievement of a defined symptom-free status and research examined outcomes reflecting daily functioning or activity level during the acute episode.

Studies report how symptoms evolved in the observed populations, and research describes patterns related to measured changes in acute physical discomfort.


Evidence for Use in General Acute Pain and Adjuvant Action

This research area explores the combination of caffeine with an analgesic. Systematic Reviews and extensive research examined how the combination was associated with outcomes in models of general acute pain, such as post-operative dental pain, in adult populations. This evidence helps contextualize how patients reported their experience when an analgesic was combined with a stimulant component, applied in studies examining whether the addition of caffeine was associated with changes in relief. The findings describe patterns observed in the studies, where the addition of caffeine to an analgesic was associated with a different pattern in the proportion of participants achieving a defined level of perceived discomfort during the study period.


What Remains Uncertain and Areas for Future Research

The overall evidence base for Cope is characterized by a significant volume of research examining the principle of combination analgesia, particularly for headache. However, several research limitations frames apply to the specific dual formulation. A known limitation is that some of the highest-weight evidence often involves a triple combination that includes Acetaminophen, meaning that comparative evidence is lacking for the specific dual formulation against all relevant comparators (e.g., ASA alone) in all indications. Furthermore, studies conducted during periods of increased symptom activity have primarily focused on acute, single-dose efficacy. Crucially, long-term effects are not fully established for this combination, and subgroup findings are uncertain for specific populations, including those with certain comorbidities.

Frequently Asked Questions (FAQ)

Common questions about Cope (FAQ)


Q: Is Cope an opioid or does it contain controlled substances?

Cope is a combination of a nonsteroidal anti-inflammatory drug (NSAID) and a central nervous system stimulant. The active ingredient, Acetylsalicylic Acid (Aspirin), is not classified as an opioid and is not a controlled substance under U.S. or major international drug scheduling systems. The combination product is generally not scheduled.


Q: If I miss a dose of Cope, what general information is available?

This medicine is intended for use 'as needed' and not on a continuous, scheduled basis. If a dose is missed, official labeling indicates it should only be taken if your symptoms are still present, maintaining the minimum 6-hour interval between doses. Regulatory documents indicate that extra medication should not be taken to make up for a missed dose.


Q: What is the longest period of time people typically use Cope?

Regulatory labels establish strict limits on the duration of non-prescription use. The medicine is not intended for typical continuous, long-term use and is restricted to a maximum of 10 days for pain and 3 days for fever.


Q: How is Cope different from other treatments for the same condition?

This medicine is a unique dual combination of Acetylsalicylic Acid (an NSAID) and Caffeine (a stimulant). The official documents note that the Caffeine component provides an adjuvant effect, which is described as increasing the speed and magnitude of the analgesic component's pain relief compared to single-ingredient pain relievers.


Q: What happens if I forget to take Cope for a few days?

Because this product is for short-term, temporary relief, forgetting to take it for a few days is not typically a medical concern. The product is only intended to be resumed when symptoms recur, adhering to the mandated time interval between doses.


Q: Can I drive or operate machinery while taking Cope according to safety guidelines?

Official safety documents list nervous system side effects such as Dizziness and Nervousness. Official documents describe that individuals who experience these effects are typically advised to exercise caution before driving or operating machinery.


Q: Why do some people experience mild nausea when starting Cope?

Nausea is a commonly reported side effect, which is often linked to the Acetylsalicylic Acid component’s potential to irritate the gastrointestinal lining. The product label states that taking the dose with food or milk may be done if stomach upset occurs.


Q: Is there a generic version of Cope available?

Since this is a common, multi-ingredient, over-the-counter analgesic formulation containing established active components, generic versions with the same active ingredients (Acetylsalicylic Acid and Caffeine) are generally available.


Q: Is the research evidence for Cope considered strong or limited?

Studies and official information indicate the evidence for using this combination in acute conditions like headache is extensive, primarily documented through short-term trials. However, regulatory documents also note a limitation in that comparative long-term effects for this specific dual combination are not fully established.


Q: Is there a risk of dependency or withdrawal with Cope?

The Aspirin component is not associated with dependency. However, the Caffeine component is a central nervous system stimulant, and regular, frequent intake of high doses of caffeine can be associated with symptoms of withdrawal, such as headache, upon sudden cessation.


Q: What is known about the use of Cope during pregnancy or breastfeeding?

Official information advises against using the Aspirin component at 20 weeks of pregnancy or later due to potential risks to the fetus. The official warning indicates that a healthcare professional must be consulted before use if pregnant or breastfeeding. Aspirin is generally avoided during lactation due to potential risks for the infant.


Q: Is Cope a new drug, or has it been used for a long time?

One of the active ingredients, Acetylsalicylic Acid (Aspirin), has been available for over 100 years. This combination of Aspirin and Caffeine has been a well-established and broadly used over-the-counter formulation for several decades.


Q: Is it true that Cope can affect blood pressure?

Yes, official warnings advise that patients with high blood pressure are directed to consult a doctor before using this product. The Caffeine component can also cause an increase in systemic vascular resistance, which may result in a temporary elevation of blood pressure.


Q: What are the less common, but serious, side effects associated with Cope?

In addition to the most serious warnings (like GI bleeding and Reye’s syndrome), less common but serious side effects can include intracranial hemorrhage or severe respiratory reactions (bronchospasm). These are documented in authoritative sources to inform users of potential, although infrequent, risks.


Q: Is Cope effective for all types of pain or only specific kinds?

According to regulatory documents, Cope is officially indicated for the temporary relief of mild to moderate pain, including headache, backache, muscle aches, toothache, and minor arthritis pain. It is not indicated for the treatment of severe or chronic pain.


Q: How does official guidance describe the safety classification of Cope?

The product is officially classified as an Over-The-Counter (OTC) combination analgesic. Pharmacologically, its active ingredients are classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and a Central Nervous System (CNS) Stimulant.


Q: Can the drug be crushed or split?

Official instructions for the tablet/caplet form specify that the unit should be swallowed whole with a full glass of water. Regulatory documents do not typically authorize or provide instructions for crushing or splitting the oral unit, as this may affect absorption and stomach safety.


Q: Can Cope be taken on an empty stomach?

The product label notes that the dose may be taken alongside food or milk if stomach upset occurs, as the Aspirin component can irritate the stomach lining. While not strictly forbidden, taking it with food or milk may reduce the likelihood of stomach discomfort.


Q: Are there any specific foods or drinks that should be avoided with Cope?

Official warnings require restricting the intake of alcohol due to the increased risk of stomach bleeding. Users are also advised to limit the use of caffeine-containing products (such as coffee, tea, and energy drinks) to avoid excessive stimulant effects.


Q: Are there any known interactions between Cope and herbal supplements?

Regulatory labels do not specifically list all herbal supplements. However, due to the bleeding risk associated with the Aspirin component, caution is advised. Official guidance indicates that consultation with a healthcare professional is necessary if taking any supplements known to affect blood clotting.


Q: Is Cope safe to take if I have liver or kidney issues (in general terms)?

Official labeling states that users with liver disease or kidney disease are directed to consult a doctor before using this medicine. This is due to the potential for the active ingredients to affect these organs or be cleared less efficiently by the body.


Q: Does Cope affect sleep patterns?

Yes, the Caffeine component is a central nervous system stimulant and can cause sleep disturbances. Insomnia and sleeplessness are listed as common side effects, and official warnings advise limiting total caffeine intake to avoid these effects.


Q: Are there any contraindications related to mental health conditions listed for Cope?

Official documents do not list absolute contraindications based solely on specific mental health conditions. However, caution is advised, as the stimulant component (Caffeine) can cause nervousness, irritability, and may potentially exacerbate symptoms in patients with underlying psychiatric disorders.


Q: Does Cope interact with birth control pills?

Yes, the official interaction profile lists Oral Contraceptives as a medicinal product category with documented interactions. These interactions may alter the body's clearance of the active components of the medicine.


Q: What are the eligibility criteria for using Cope?

General eligibility requires the user to be an adult or a child 12 years of age or older. Users are ineligible if they have a documented allergy to Aspirin or NSAIDs. Furthermore, official documents indicate that a doctor must be consulted if the user has conditions such as severe asthma, bleeding problems, or heart, liver, or kidney disease.

How should Cope be stored and disposed of?

Official Storage Requirements

This medication, an acetaminophen, aspirin, and caffeine combination, must be stored at controlled room temperature, which is defined as 20 C to 25 C (68 F to 77 F). The regulatory labeling permits brief temperature excursions between 15 C and 30 C. To maintain product integrity and stability, the container's cap must be closed tightly after each use.


Child Safety and Disposal

For safety, the product must always be kept out of reach of children. When disposing of unused or expired medicine, the official guidance is to utilize a drug take-back program. If a program is not available, the tablets should be mixed with an undesirable substance (such as used coffee grounds) and sealed in a bag for disposal in the household trash. This medicine is not on the list of products recommended for flushing down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cope found in:

A-Z Index: